by Sean Hughes | Nov 1, 2016 | US & International
Introduction The Cancer Immunotherapy Pilot Program, also known as “Patents 4 Patients”, makes certain US patent applications relating to cancer immunotherapy eligible for special status and examination with the goal of completing prosecution within 12...
by Alex Bajjon | Nov 1, 2016 | EPO
Article 72 of the European Patent Convention states that an assignment of a European patent application shall be made in writing and shall require the signature of the parties to the contract. Such assignments can be recorded centrally at the EPO for pending...
by Dr Andrew Clements | Oct 16, 2016 | Briefings, UK
Changes effective 1 October 2016 Notification of intention to grant The UKIPO is to issue advance notification of grant in order to allow patent applicants the opportunity to file a divisional application without the need to recourse to the current practice of...
by Sean Hughes | Oct 1, 2016 | EPO
Introduction In decisions G 2/12 (“Broccoli II”) and G 2/13 (“Tomatoes II”), the Enlarged Board of Appeal (EBA) of the European Patent Office (EPO) found that plants and products thereof, e.g. seeds and fruits, are patentable. This is the case...
Recent Comments